Karkinos Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.30 M
as on 16-11-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 278.04 Cr
as on 16-11-2024
- Revenue 1504.00%
(FY 2023)
- Profit -228.15%
(FY 2023)
- Ebitda -250.42%
(FY 2023)
- Net Worth 77.66%
(FY 2023)
- Total Assets 147.89%
(FY 2023)
About Karkinos Healthcare
- CIN/LLPIN
U93090MH2020PTC342527
- Company No.
342527
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Karkinos Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkataramanan Ramachandran | CEO | 01-Sep-2020 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sundar Sethurathnam  | Director | 31-Aug-2022 | Current |
| Laliteshkumar Katragadda | Director | 31-Aug-2022 | Current |
| Deepak Kharwad | Director | 10-Aug-2020 | Current |
Biju Samkutty  | Nominee Director | 31-Aug-2022 | Current |
| Divya Murthy | Director | 06-Jan-2023 | Current |
| Arghya Sengupta | Director | 31-Aug-2022 | Current |
Financial Performance and Corporate Structure Insights of Karkinos Healthcare.
Karkinos Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1504% increase. The company also saw a substantial fall in profitability, with a 228.15% decrease in profit. The company's net worth Soared by an impressive increase of 77.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Karkinos Healthcare?
In 2022, Karkinos Healthcare had a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Karkinos Healthcare Technologies Kerala Private LimitedActive 3 years 10 monthsDeepak Kharwad and Venkataramanan Ramachandran are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Jan 2024 | ₹6.40 Cr | Open |
Others Creation Date: 25 Sep 2023 | ₹6.14 Cr | Open |
Tata Capital Financial Services Limited Creation Date: 25 Sep 2023 | ₹25.00 Cr | Open |
How Many Employees Work at Karkinos Healthcare?
Karkinos Healthcare has a workforce of 475 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Karkinos Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karkinos Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
